The May 29 issue of The Los Angeles Times published an interesting article on a trend among health insurers (including those operating nationally, such as Aetna) to require patients to pay a great deal more out of pocket for high-cost specialty drugs used to treat such things as cancer and rheumatoid arthritis.
by 